A detailed history of Sage Rhino Capital LLC transactions in Organon & Co. stock. As of the latest transaction made, Sage Rhino Capital LLC holds 15,164 shares of OGN stock, worth $302,218. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,164
Previous 13,608 11.43%
Holding current value
$302,218
Previous $196,000 45.41%
% of portfolio
0.07%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$13.78 - $18.8 $21,441 - $29,252
1,556 Added 11.43%
15,164 $285,000
Q4 2023

Feb 05, 2024

BUY
$10.95 - $17.32 $149,007 - $235,690
13,608 New
13,608 $196,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.07B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Sage Rhino Capital LLC Portfolio

Follow Sage Rhino Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.